Workflow
便携式肺功能仪
icon
Search documents
2025年中国肺功能仪行业市场政策、产业链图谱、采购规模、竞争格局及发展趋势研判:外资品牌占据主导地位[图]
Chan Ye Xin Xi Wang· 2025-12-14 02:04
肺功能仪即肺功能测试仪,是用于测量由肺部吸入和呼出的空气体积的一种医疗器械,可以分析受测者 呼出气体的一系列参数,如氧气含量、二氧化碳含量、肺活量(SVC)、用力肺活量(FVC)、每分钟 通气量(MV)等,用以整体了解受测者肺功能的基本状态,对受试者肺功能、有氧运动能力、能量消 耗等进行评价,判断肺功能是否存在障碍,以及评估障碍的程度及类型。 肺功能仪的使用优点 内容概要:受空气污染、人口老龄化加剧、不良生活方式等诸多因素影响,近年来,我国呼吸系统疾病 患病率持续攀升,尤其是老年人,老年人呼吸道黏膜萎缩、肺功能衰退,对病原体和环境刺激的抵抗力 减弱,患病率更高,但此前肺功能检查的临床普及率长期偏低,随着居民健康意识提升,无论是医疗机 构的临床诊断需求,还是患者居家监测、健康人群体检的筛查需求,都在持续释放,据比地招标网数据 显示,2024年我国肺功能仪采购总额为4.22亿元,与2023年基本持平,但由于采购均价上涨,2024年我 国肺功能仪采购总量下滑明显,降至1602台。 相关上市企业:美好医疗(301363)、康泰医学(300869) 相关企业:浙江柯洛德健康科技有限公司、广州红象医疗科技有限公司、武汉珈 ...
研判2025!中国便携式肺功能仪行业发展背景、产业链、发展现状、企业分析及未来前景展望:人口老龄化带动需求,行业市场规模有望持续增长[图]
Chan Ye Xin Xi Wang· 2025-11-13 01:17
Core Insights - The portable spirometer market in China is projected to reach 444 million yuan in 2024, reflecting a year-on-year increase of 9% driven by policy support and rising demand [1][7]. Industry Overview - Portable spirometers are essential medical devices for lung function testing, first introduced by Breath Home in 2014, and have received certifications from NMPA, FDA, and CE [3]. - These devices are compact, easy to carry, and suitable for various settings, including community health service centers and home monitoring, facilitating early detection of chronic respiratory diseases [3][4]. Market Dynamics - The aging population in China is increasing, with the elderly population expected to reach 219.69 million by the end of 2024, contributing to a higher prevalence of chronic respiratory diseases and a growing demand for lung function tests [4]. - The number of medical institutions in China is projected to reach 1,093,600 by 2024, a year-on-year increase of 2.13%, indicating a growing market for portable spirometers [5]. Competitive Landscape - The market has historically been dominated by international brands like Jaeger and R spirometry, but domestic companies such as Mindray, Yuyue Medical, and Kangtai Medical are gaining market share through innovation and expansion [9]. - Mindray reported a revenue of 25.834 billion yuan in the first three quarters of 2025, a decrease of 12.38% year-on-year, while Kangtai Medical achieved a revenue of 344 million yuan in the first half of 2025, an increase of 3.03% year-on-year [10][11]. Development Trends - The industry is expected to see continuous technological innovation and product upgrades, with the integration of IoT, big data, and AI enhancing the precision and intelligence of portable spirometers [11]. - Competition is intensifying as both domestic and international brands increase R&D investments and market efforts, leading to potential mergers and acquisitions within the industry [12]. - The pace of domestic substitution is accelerating, with local manufacturers poised to replace imported products as they enhance their technological capabilities and market presence [13].